Cell Softness Prevents Cytolytic T-cell Killing of Tumor-Repopulating Cells
نویسندگان
چکیده
Abstract Biomechanics is a fundamental feature of cell. However, the manner by which actomysin tension affects tumor immune evasion remains unclear. Here we show that although cytotoxic T lymphocytes (CTL) can effectively destroy stiff differentiated cells, they fail to kill soft tumor-repopulating cells (TRC). TRC softness prevented membrane pore formation caused CTL-released perforin. Perforin interacting with nonmuscle myosin heavy-chain 9 transmitted forces less F-actins in TRC, thus generating an inadequate contractile force for perforin formation. Stiffening allowed ability drill through membrane, leading CTL-mediated killing TRC. Importantly, overcoming mechanical human also enhanced cell death CTL, potentiating mechanics-based immunotherapeutic strategy. These findings reveal mechanics-mediated evasion, potentially providing alternative approach immunotherapy. Significance: Tumor-repopulating evade CD8+ cytolytic T-cell mechanism, underlying impediment at synapse site.
منابع مشابه
Cell, Tumor, and Stem Cell Biology Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8 Cytolytic T Cells
Solid tumors contain a subset of stem-like cells that are resistant to the cytotoxic effects of chemotherapy/radiotherapy, but their susceptibility to cytolytic T lymphocyte (CTL) effector mechanisms has not been well characterized. Using a panel of early-passage human brain tumor stem/initiating cell (BTSC) lines derived from high-grade gliomas, we show that BTSCs are subject to immunologic re...
متن کاملThe Epigenetic Regulation of Blinatumomab Gene Expression: Tumor Cell-dependent T cell Response against Lymphoma Cells and Cytotoxic Activity
Conventional treatment for cancer such as surgical resection and chemotherapy can cause damage in cases with advanced cancers. Moreover, the identification of tumor-specific targets has great importance in T-cell therapies. For decades, T cell activity has been stimulated to improve anti-tumor activity. Bispecific antibodies have attracted strong interest from pharmaceutical companies, for thei...
متن کاملRecognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.
Solid tumors contain a subset of stem-like cells that are resistant to the cytotoxic effects of chemotherapy/radiotherapy, but their susceptibility to cytolytic T lymphocyte (CTL) effector mechanisms has not been well characterized. Using a panel of early-passage human brain tumor stem/initiating cell (BTSC) lines derived from high-grade gliomas, we show that BTSCs are subject to immunologic re...
متن کاملEfficient extravasation of tumor-repopulating cells depends on cell deformability
Cancer metastasis is the most deadly stage in cancer progression. Despite significant efforts over the past decades, it remains elusive why only a very small fraction of cancer cells is able to generate micrometastasis and metastatic colonization. Recently we have shown that tumor-repopulating cells (TRCs), a highly tumorigenic subpopulation of mouse melanoma cells, can be selected by being cul...
متن کاملProducing Soluble Human Programmed Cell Death Protein-1: A Natural supporter for CD4+T cell Cytotoxicity and Tumor Cells Apoptosis
Background: Programmed cell death protein-1 (PD-1)/PD-L1 pathway is one of the immune checkpoint pathways involved in regulation of the immune responses and suppression of anti-tumor defense. PD-1/B7-H1-blocking antibodies improve immune responses such as cytotoxic activity of CD8+/CD4+T cells and also increase mortality of tumor cells; however their use is accompanied by adverse effects in pat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Research
سال: 2021
ISSN: ['1538-7445', '0008-5472']
DOI: https://doi.org/10.1158/0008-5472.can-20-2569